Home > Signaling Pathways>Metabolic Enzyme/Protease>Phospholipase>Quinacrine 2HCl (Mepacrine; SN-390)
Quinacrine 2HCl (Mepacrine; SN-390)

This product is for research use only, not for human use. We do not sell to patients.

Quinacrine 2HCl (Mepacrine; SN-390)
For small sizes, please check our retail website as below: www.invivochem.com
Size Price Stock
1g$150Check With Us
10g$450Check With Us
20g$675Check With Us

Cat #: V1970 CAS #: 69-05-6 Purity ≥ 98%

Description: Quinacrine 2HCl (Mepacrine; SN-390) is a lipophilic cationic drug with multiple actions that is commonly used as an anti-protozoal agent.

References: Xiaoyang Wu, et al. Quinacrine Inhibits Cell Growth and Induces Apoptosis in Human Gastric Cancer Cell Line SGC-7901. Curr Ther Res Clin Exp. 2012 Feb;73(1-2):52-64.

Top Publications Citing Invivochem Products
Publications Citing InvivoChem Products

Product Promise

Promise
Molecular Weight (MW)472.88
Molecular FormulaC23H30ClN3O.2HCl
CAS No.69-05-6
Storage-20℃ for 3 years in powder formr
-80℃ for 2 years in solvent
Solubility In VitroDMSO: 14 mg/mL (29.6 mM)r
Water: 53 mg/mL (112.1 mM)r
Ethanol: 28 mg/mL (59.2 mM)
SMILES CodeCC(NC1=C(C=C(OC)C=C2)C2=NC3=CC(Cl)=CC=C31)CCCN(CC)CC.[H]Cl.[H]Cl
SynonymsSN 390; SN-390; SN390; ST 439; AI3-04467; ST439; AI304467; Acrichine; Acrinamine; Acriquine; mepacrine dihydrochoride; atabrine.
ProtocolIn VitroQuinacrine (15 μM; 24 hours) treatment significantly increased the levels of proapoptotic proteins, including cytochrome c, Bax, and p53, and decreased the levels of antiapoptotic protein Bcl-2, thus shifting the ratio of Bax/Bcl-2 in favor of apoptosis. Quinacrine (7.5 and 15 μM; 24 hours) induces apoptosis in SGC-7901 cells, which is associated with mitochondria-dependent signal pathway and involves p53 upregulation and caspase-3 activation pathway. Quinacrine (5-20 μM; 24 hours) inhibits the growth of SGC-7901 cells.
In VivoQuinacrine (100 mg/kg three times per week for two consecutive weeks) significantly suppresses circulating blast cells at days 30/31 and increases the median survival time (MST). Quinacrine does not decrease the body weight of treated animals at the tested dose.
These protocols are for reference only. InvivoChem does not independently validate these methods.
Preparing Stock Solutions
Solvent volume to be added Mass (the weight of a compound)
Mother liquor concentration 1mg5mg10mg20mg
1mM2.1147 mL10.5735 mL21.1470 mL42.2940 mL
5mM0.4229 mL2.1147 mL4.2294 mL8.4588 mL
10mM0.2115 mL1.0574 mL2.1147 mL4.2294 mL
20mM0.1057 mL0.5287 mL1.0574 mL2.1147 mL
Quality Control Documentation
The molarity calculator equation
Mass(g) = Concentration(mol/L) × Volume(L) × Molecular Weight(g/mol)
Mass
=
Concentration
×
Volume
×
Molecular Weight*
The dilution calculator equation
Concentration(start) × Volume(start) = Concentration(final) × Volume(final)

This equation is commonly abbreviated as: C1 V1 = C2 V2

Concentration(start)
C1
×
Volume(start)
V1
=
Concentration(final)
C2
×
Volume(final)
V2
Step One: Enter information below
Dosage mg/kg Average weight of animals g Dosing volume per animal µL Number of animals
Step Two: Enter the in vivo formulation
%DMSO + % + %Tween 80 + %ddH2O

Calculation Results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in µL DMSO(Master liquid concentration mg/mL) ,Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation: Take µL DMSO master liquid, next add µL PEG300, mix and clarify, next add µL Tween 80,mix and clarify, next add µL ddH2O,mix and clarify.
Note:
  • (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
  • (2) Be sure to add the solvent(s) in order.